Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.
Human pluripotent stem cells (PSC) have the potential to revolutionize regenerative medicine. However undifferentiated PSC can form tumors and strict quality control measures and safety studies must be conducted before clinical translation. Here we describe preclinical tumorigenicity and biodistribution safety studies that were required by the US Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) prior to conducting a Phase I clinical trial evaluating the safety and tolerability of human parthenogenetic stem cell derived neural stem cells ISC-hpNSC for treating Parkinson's disease (ClinicalTrials.gov Identifier NCT02452723). To mitigate the risk of having residual PSC in the final ISC-hpNSC population, we conducted sensitive in vitro assays using flow cytometry and qRT-PCR analyses and in vivo assays to determine acute toxicity, tumorigenicity and biodistribution. The results from these safety studies show the lack of residual undifferentiated PSC, negligible tumorigenic potential by ISC-hpNSC and provide additional assurance to their clinical application.
International Stem Cell Corporation, Carlsbad, CA, USA.
Ibon
I
Garitaonandia
International Stem Cell Corporation, Carlsbad, CA, USA.
Rodolfo
R
Gonzalez
International Stem Cell Corporation, Carlsbad, CA, USA.
Trudy
T
Christiansen-Weber
International Stem Cell Corporation, Carlsbad, CA, USA.
Tatiana
T
Abramihina
International Stem Cell Corporation, Carlsbad, CA, USA.
Maxim
M
Poustovoitov
International Stem Cell Corporation, Carlsbad, CA, USA.
Alexander
A
Noskov
International Stem Cell Corporation, Carlsbad, CA, USA.
Glenn
G
Sherman
International Stem Cell Corporation, Carlsbad, CA, USA.
Andrey
A
Semechkin
Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, USA.
Evan
E
Snyder
International Stem Cell Corporation, Carlsbad, CA, USA.
Russell
R
Kern
Cell Stem Cell. 2014 Nov 6;15(5):634-42
25517467
Regen Med. 2015;10(2):99-102
25835474
J Neurosci. 2009 Jan 21;29(3):798-810
19158305
J Comp Neurol. 2002 Apr 8;445(3):238-55
11920704
Endocr Rev. 2009 May;30(3):204-13
19366754
Cell Transplant. 2016 May 20;:
27213850
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12175-80
17586681
Cell Stem Cell. 2011 Jan 7;8(1):106-18
21211785
Mol Ther. 2010 Jul;18(7):1249-50
20596063
Cell Transplant. 2015;24(4):681-90
25839189
Science. 1998 Nov 6;282(5391):1145-7
9804556
Cell. 2013 Jun 6;153(6):1228-38
23683578
J Neurol Sci. 2005 Dec 15;239(1):45-52
16225890
Cloning Stem Cells. 2008 Mar;10(1):11-24
18092905
Stem Cell Reports. 2014 May 15;2(6):825-37
24936469
J Biol Chem. 2014 Feb 21;289(8):4578-84
24362040
Stem Cells Transl Med. 2014 Mar;3(3):290-8
24443005
Lancet. 2015 Feb 7;385(9967):509-16
25458728
Regul Toxicol Pharmacol. 2008 Apr;50(3):345-52
18295384
Bioessays. 2016 Jul;38 Suppl 1:S86-95
27417126
Stem Cells Transl Med. 2015 Oct;4(10):1214-22
26304037
Cell Stem Cell. 2010 Oct 8;7(4):483-95
20887954
Stem Cell Res. 2009 May;2(3):198-210
19393593
Sci Transl Med. 2012 Aug 15;4(147):147fs28
22896673
Lancet. 2012 Feb 25;379(9817):713-20
22281388
Cloning Stem Cells. 2007 Fall;9(3):432-49
17594198
PLoS One. 2012;7(5):e37342
22615985
Nat Biotechnol. 2009 Mar;27(3):213-4
19270655
PLoS One. 2015 Feb 25;10(2):e0118307
25714340
Neuropsychopharmacology. 2002 Aug;27(2):143-51
12093588
Stem Cells Transl Med. 2013 Dec;2(12):961-74
24191264
J Clin Med. 2015 Jan 14;4(1):159-71
26237025
Br Med Bull. 2013;108:73-94
24200742
Nat Med. 2013 Aug;19(8):998-1004
23921754
Nat Biotechnol. 2009 Jul;27(7):606-13
19587662
Stem Cells Transl Med. 2012 May;1(5):353-8
23197814
J Neurosci Methods. 2009 Jan 30;176(2):200-5
18809434
Eur J Health Law. 2015 Jun;22(3):267-86
26399046
Sci Rep. 2013;3:1463
23492920
Stem Cell Reports. 2016 Jun 14;6(6):787-97
27185282
Cell. 2007 Nov 30;131(5):861-72
18035408
Regul Toxicol Pharmacol. 2009 Aug;54(3):301-7
19477212
PLoS One. 2014 Jan 14;9(1):e85336
24454843
Nat Rev Mol Cell Biol. 2016 Mar;17(3):194-200
26908143
Cell Stem Cell. 2015 Jul 2;17(1):11-22
26140604
Cell Cycle. 2009 Aug 15;8(16):2608-12
19597339
Lancet. 2016 May 14;387(10032):1979-81
27179752